UI study: Bone-loss drug shows promise against cancer

A drug used to treat bone loss has potential to be a cancer drug 200 times better at killing tumor cells than similar drugs, a University of Illinois professor said Wednesday.

The UI has been leading 24 researchers from the U.S., Europe, Taiwan and Japan for about four years in the study, which appears in this week's issue of the Journal of the American Chemical Society.

Also on this date

• UI President White addresses legislative committee
• Fabri to quit as Champaign County Democratic chairman
• Stimulus funds to help more people weatherize homes
• Fundraiser set for families of EIU students killed in crash
• CASAblanca event canceled over lack of ticket sales
• UI's I space gallery faces closure by end of summer
• Urbana mayoral candidate taking ballot issue to court
• Diocese considers closing St. Mary's in Westville
• Legislators differ on closure of agency's Paxton office
• Obituaries

» More